Clinical Trial Update: Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluates the combination of monoclonal antibody therapy with etoposide for neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Etoposide (Etoposide)
• Unspecified monoclonal antibody therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED